Neetu Agashivala

Persistence with and adherence to fingolimod compared with other disease-modifying therapies for the treatment of multiple sclerosis: a retrospective US claims database analysis

Niklas Bergvall, Allison Petrilla, Swapna Karkare et al. · Journal of Medical Economics · 2014 · 91 citations

Pharmacy, Neurology, Pharmacotherapy +15

Compliance to fingolimod and other disease modifying treatments in multiple sclerosis patients, a retrospective cohort study

Neetu Agashivala, Ning Wu, Safiya Abouzaid et al. · BMC Neurology · 2013 · 87 citations · Full text

Pharmacy, Clinical Pharmacy, Pharmacotherapy +15

Relapse Rates in Patients with Multiple Sclerosis Switching from Interferon to Fingolimod or Glatiramer Acetate: A US Claims Database Study

Niklas Bergvall, Charles Makin, Raquel Lahoz et al. · PLoS ONE · 2014 · 70 citations · Full text

Medicine, Neurology, Pharmacotherapy +16

Comparison of patient characteristics and gout-related health-care resource utilization and costs in patients with frequent versus infrequent gouty arthritis attacks

Joseph J. Saseen, Neetu Agashivala, Richard R. Allen et al. · Lara D. Veeken · 2012 · 55 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17

Direct and indirect cost burden associated with multiple sclerosis relapses: Excess costs of persons with MS and their spouse caregivers

Hélène Parisé, François Laliberté, Patrick Lefèbvre et al. · Journal of the Neurological Sciences · 2013 · 48 citations

Pharmacy, Neurology, Pharmacoeconomics +13